Clinical Trial Update: Tirzepatide to Slow Biological Aging [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating whether tirzepatide can slow biological aging is currently recruiting at UTMB.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Aging, LONGEVITY 1 | Phase 2 | Status: RECRUITING